rs376823689
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_004366.6(CLCN2):c.2386C>T(p.Gln796*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004366.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy with mild cerebellar ataxia and white matter edemaInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- epilepsy, idiopathic generalized, susceptibility to, 11Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- familial hyperaldosteronism type IIInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004366.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CLCN2 | NM_004366.6 | MANE Select | c.2386C>T | p.Gln796* | stop_gained | Exon 22 of 24 | NP_004357.3 | ||
| CLCN2 | NM_001171087.3 | c.2335C>T | p.Gln779* | stop_gained | Exon 22 of 24 | NP_001164558.1 | |||
| CLCN2 | NM_001171089.3 | c.2386C>T | p.Gln796* | stop_gained | Exon 22 of 23 | NP_001164560.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CLCN2 | ENST00000265593.9 | TSL:1 MANE Select | c.2386C>T | p.Gln796* | stop_gained | Exon 22 of 24 | ENSP00000265593.4 | ||
| CLCN2 | ENST00000344937.11 | TSL:1 | c.2335C>T | p.Gln779* | stop_gained | Exon 22 of 24 | ENSP00000345056.7 | ||
| CLCN2 | ENST00000430397.5 | TSL:1 | n.*776+251C>T | intron | N/A | ENSP00000396231.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The Q796X variant in the CLCN2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Q796X variant is observed in 1/15302 (0.0065%) alleles from individuals of African background in large population cohorts (Lek et al., 2016). We interpret Q796X as a likely pathogenic variant.
Leukoencephalopathy with mild cerebellar ataxia and white matter edema Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at